 Mark Dell'Acqua
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| A Kinase Anchor Proteins | 36 | 2024 | 72 | 7.810 |
Why?
| | Calcium Channels, L-Type | 12 | 2025 | 118 | 4.200 |
Why?
| | Calcineurin | 23 | 2026 | 108 | 4.150 |
Why?
| | Synapses | 22 | 2025 | 436 | 4.090 |
Why?
| | Long-Term Potentiation | 20 | 2024 | 200 | 4.020 |
Why?
| | Dendritic Spines | 13 | 2024 | 69 | 3.550 |
Why?
| | Receptors, AMPA | 14 | 2024 | 143 | 3.120 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 18 | 2021 | 128 | 3.070 |
Why?
| | Neuronal Plasticity | 14 | 2024 | 305 | 3.020 |
Why?
| | Calcium | 14 | 2025 | 1183 | 2.590 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 14 | 2024 | 227 | 2.540 |
Why?
| | Long-Term Synaptic Depression | 10 | 2024 | 55 | 2.150 |
Why?
| | Hippocampus | 28 | 2025 | 948 | 2.030 |
Why?
| | Neurons | 24 | 2025 | 1636 | 2.000 |
Why?
| | NFATC Transcription Factors | 10 | 2024 | 94 | 1.960 |
Why?
| | Amyloid beta-Peptides | 5 | 2024 | 235 | 1.880 |
Why?
| | Cell Nucleus | 5 | 2025 | 612 | 1.780 |
Why?
| | Signal Transduction | 24 | 2024 | 5214 | 1.630 |
Why?
| | Dendrites | 6 | 2025 | 105 | 1.430 |
Why?
| | Calcium Signaling | 7 | 2025 | 248 | 1.380 |
Why?
| | Phosphoric Monoester Hydrolases | 4 | 2018 | 55 | 1.360 |
Why?
| | Synaptic Transmission | 7 | 2024 | 295 | 1.240 |
Why?
| | Receptors, GABA-A | 6 | 2024 | 143 | 1.230 |
Why?
| | Adaptor Proteins, Signal Transducing | 10 | 2007 | 441 | 1.100 |
Why?
| | Stromal Interaction Molecule 1 | 3 | 2024 | 10 | 1.040 |
Why?
| | Lipoylation | 5 | 2018 | 17 | 0.960 |
Why?
| | Animals | 67 | 2025 | 38010 | 0.920 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 8 | 2024 | 197 | 0.870 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2025 | 146 | 0.870 |
Why?
| | ORAI1 Protein | 1 | 2024 | 3 | 0.870 |
Why?
| | Endosomes | 3 | 2018 | 144 | 0.870 |
Why?
| | Rats | 26 | 2025 | 5610 | 0.870 |
Why?
| | Cells, Cultured | 19 | 2025 | 4182 | 0.860 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2024 | 38 | 0.850 |
Why?
| | Protein Binding | 14 | 2024 | 2261 | 0.810 |
Why?
| | Rats, Sprague-Dawley | 18 | 2025 | 2531 | 0.800 |
Why?
| | Endoplasmic Reticulum | 3 | 2024 | 263 | 0.790 |
Why?
| | MAP Kinase Signaling System | 1 | 2025 | 325 | 0.760 |
Why?
| | Carrier Proteins | 8 | 2024 | 752 | 0.750 |
Why?
| | Mice, Inbred C57BL | 14 | 2024 | 6043 | 0.720 |
Why?
| | Protein Transport | 8 | 2021 | 447 | 0.650 |
Why?
| | Phosphorylation | 18 | 2026 | 1781 | 0.640 |
Why?
| | Membrane Proteins | 11 | 2024 | 1171 | 0.630 |
Why?
| | MAP Kinase Kinase 7 | 1 | 2018 | 8 | 0.590 |
Why?
| | Mice | 28 | 2024 | 18378 | 0.590 |
Why?
| | Presynaptic Terminals | 3 | 2021 | 94 | 0.580 |
Why?
| | Acyltransferases | 2 | 2018 | 81 | 0.570 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 82 | 0.570 |
Why?
| | Phosphoprotein Phosphatases | 2 | 2015 | 65 | 0.560 |
Why?
| | Protein Isoforms | 2 | 2018 | 404 | 0.540 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2018 | 142 | 0.530 |
Why?
| | Homeostasis | 3 | 2021 | 641 | 0.510 |
Why?
| | COS Cells | 8 | 2018 | 179 | 0.510 |
Why?
| | Excitatory Postsynaptic Potentials | 5 | 2021 | 124 | 0.490 |
Why?
| | Mice, Inbred C3H | 1 | 2016 | 257 | 0.480 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2016 | 97 | 0.470 |
Why?
| | Enzyme Inhibitors | 2 | 2016 | 839 | 0.460 |
Why?
| | Nerve Tissue Proteins | 4 | 2015 | 607 | 0.460 |
Why?
| | Amyloid | 1 | 2016 | 96 | 0.450 |
Why?
| | Guanylate Kinases | 4 | 2012 | 15 | 0.440 |
Why?
| | Nervous System Diseases | 1 | 2017 | 280 | 0.440 |
Why?
| | Mice, Transgenic | 5 | 2024 | 2194 | 0.430 |
Why?
| | HEK293 Cells | 7 | 2026 | 748 | 0.430 |
Why?
| | Exocytosis | 1 | 2015 | 83 | 0.430 |
Why?
| | Peptide Fragments | 4 | 2016 | 698 | 0.420 |
Why?
| | Transcriptional Activation | 1 | 2014 | 380 | 0.360 |
Why?
| | CA1 Region, Hippocampal | 2 | 2022 | 50 | 0.360 |
Why?
| | Receptors, Glutamate | 2 | 2021 | 26 | 0.360 |
Why?
| | Type C Phospholipases | 2 | 2007 | 71 | 0.350 |
Why?
| | Action Potentials | 5 | 2019 | 513 | 0.340 |
Why?
| | Synaptic Potentials | 3 | 2019 | 18 | 0.310 |
Why?
| | Protein Biosynthesis | 2 | 2024 | 453 | 0.310 |
Why?
| | Transfection | 6 | 2012 | 949 | 0.300 |
Why?
| | Disks Large Homolog 4 Protein | 4 | 2012 | 19 | 0.280 |
Why?
| | Cell Line | 7 | 2021 | 2897 | 0.280 |
Why?
| | Binding Sites | 8 | 2018 | 1325 | 0.260 |
Why?
| | Cell Membrane | 5 | 2021 | 708 | 0.260 |
Why?
| | Intracellular Signaling Peptides and Proteins | 4 | 2018 | 471 | 0.260 |
Why?
| | In Vitro Techniques | 4 | 2016 | 1064 | 0.260 |
Why?
| | Male | 18 | 2025 | 71501 | 0.250 |
Why?
| | MicroRNAs | 2 | 2024 | 698 | 0.240 |
Why?
| | Brain | 4 | 2019 | 2892 | 0.230 |
Why?
| | Mutation | 5 | 2022 | 4053 | 0.230 |
Why?
| | Electric Stimulation | 3 | 2016 | 281 | 0.220 |
Why?
| | Cytoplasm | 3 | 2018 | 267 | 0.220 |
Why?
| | Silver Staining | 2 | 2016 | 17 | 0.220 |
Why?
| | Synaptic Membranes | 3 | 2017 | 16 | 0.210 |
Why?
| | Habenula | 1 | 2024 | 13 | 0.210 |
Why?
| | Mutation, Missense | 1 | 2026 | 346 | 0.210 |
Why?
| | Autistic Disorder | 2 | 2022 | 212 | 0.210 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2024 | 72 | 0.200 |
Why?
| | Primary Cell Culture | 3 | 2021 | 171 | 0.200 |
Why?
| | Patch-Clamp Techniques | 6 | 2019 | 291 | 0.200 |
Why?
| | Cadherins | 1 | 2005 | 202 | 0.200 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 2 | 2007 | 32 | 0.200 |
Why?
| | Brain Injuries | 2 | 2021 | 506 | 0.200 |
Why?
| | Down-Regulation | 2 | 2015 | 644 | 0.190 |
Why?
| | Syndactyly | 1 | 2022 | 11 | 0.190 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2015 | 202 | 0.190 |
Why?
| | Analysis of Variance | 3 | 2012 | 1314 | 0.190 |
Why?
| | Amino Acid Sequence | 6 | 2018 | 2165 | 0.190 |
Why?
| | Receptors, Ionotropic Glutamate | 1 | 2021 | 1 | 0.180 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2021 | 15 | 0.180 |
Why?
| | Female | 12 | 2025 | 77252 | 0.180 |
Why?
| | Spermine | 1 | 2021 | 30 | 0.180 |
Why?
| | Amino Acid Motifs | 3 | 2019 | 226 | 0.180 |
Why?
| | Long QT Syndrome | 1 | 2022 | 69 | 0.170 |
Why?
| | KATP Channels | 1 | 2021 | 17 | 0.170 |
Why?
| | Luminescent Proteins | 3 | 2009 | 185 | 0.170 |
Why?
| | Humans | 28 | 2026 | 143560 | 0.160 |
Why?
| | Gene Knock-In Techniques | 2 | 2018 | 60 | 0.160 |
Why?
| | Optogenetics | 2 | 2023 | 111 | 0.160 |
Why?
| | N-Methylaspartate | 2 | 2012 | 43 | 0.160 |
Why?
| | Excitatory Amino Acid Agonists | 2 | 2012 | 41 | 0.160 |
Why?
| | Protein Kinase C | 3 | 2015 | 253 | 0.150 |
Why?
| | Animals, Newborn | 4 | 2015 | 882 | 0.150 |
Why?
| | Receptor Cross-Talk | 1 | 2019 | 21 | 0.150 |
Why?
| | Leptin | 1 | 2021 | 239 | 0.150 |
Why?
| | Models, Biological | 3 | 2019 | 1831 | 0.150 |
Why?
| | Serine | 2 | 2012 | 149 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2005 | 1125 | 0.140 |
Why?
| | Caveolin 1 | 1 | 2018 | 24 | 0.140 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 155 | 0.140 |
Why?
| | Protein Processing, Post-Translational | 2 | 2018 | 474 | 0.140 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2018 | 450 | 0.140 |
Why?
| | Actins | 3 | 2006 | 430 | 0.140 |
Why?
| | Cyclic AMP | 4 | 2012 | 215 | 0.140 |
Why?
| | Electrophysiological Phenomena | 1 | 2018 | 58 | 0.130 |
Why?
| | Recruitment, Neurophysiological | 1 | 2018 | 38 | 0.130 |
Why?
| | Myocytes, Cardiac | 2 | 2015 | 546 | 0.130 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2019 | 201 | 0.130 |
Why?
| | Post-Synaptic Density | 1 | 2017 | 11 | 0.130 |
Why?
| | Cell Communication | 1 | 2019 | 313 | 0.130 |
Why?
| | Models, Neurological | 1 | 2019 | 249 | 0.130 |
Why?
| | Disease Models, Animal | 4 | 2022 | 4522 | 0.130 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2018 | 261 | 0.130 |
Why?
| | Alternative Splicing | 1 | 2018 | 243 | 0.120 |
Why?
| | Excitatory Amino Acid Agents | 1 | 2016 | 5 | 0.120 |
Why?
| | Cocaine-Related Disorders | 1 | 2017 | 136 | 0.120 |
Why?
| | Insulin-Secreting Cells | 1 | 2021 | 389 | 0.120 |
Why?
| | Thiones | 1 | 2016 | 14 | 0.120 |
Why?
| | Nucleus Accumbens | 1 | 2017 | 152 | 0.120 |
Why?
| | Spine | 1 | 2017 | 179 | 0.120 |
Why?
| | Gene Knockdown Techniques | 2 | 2018 | 336 | 0.120 |
Why?
| | Transcription, Genetic | 2 | 2020 | 1511 | 0.120 |
Why?
| | Sensory Gating | 1 | 2016 | 45 | 0.120 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2015 | 54 | 0.120 |
Why?
| | Calcium Channels | 2 | 2012 | 156 | 0.110 |
Why?
| | Models, Molecular | 3 | 2016 | 1622 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2021 | 606 | 0.110 |
Why?
| | Mice, Knockout | 4 | 2016 | 3109 | 0.110 |
Why?
| | Lipoprotein Lipase | 1 | 2015 | 56 | 0.110 |
Why?
| | Shab Potassium Channels | 1 | 2015 | 18 | 0.110 |
Why?
| | Muscle Tonus | 1 | 2015 | 24 | 0.110 |
Why?
| | Fluorescence Resonance Energy Transfer | 3 | 2021 | 177 | 0.110 |
Why?
| | Species Specificity | 1 | 2016 | 577 | 0.110 |
Why?
| | Proteins | 2 | 1998 | 1022 | 0.110 |
Why?
| | Acoustic Stimulation | 1 | 2016 | 325 | 0.110 |
Why?
| | Glutamic Acid | 3 | 2023 | 259 | 0.110 |
Why?
| | Kinetics | 2 | 2016 | 1628 | 0.110 |
Why?
| | Leukotrienes | 1 | 2014 | 28 | 0.110 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2014 | 35 | 0.100 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channels | 1 | 2013 | 11 | 0.100 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2013 | 8 | 0.100 |
Why?
| | Receptors, Immunologic | 1 | 2015 | 207 | 0.100 |
Why?
| | Protein Structure, Tertiary | 2 | 2009 | 863 | 0.100 |
Why?
| | Cognition Disorders | 2 | 2015 | 523 | 0.100 |
Why?
| | Substrate Specificity | 3 | 2026 | 383 | 0.100 |
Why?
| | Neurodegenerative Diseases | 1 | 2015 | 143 | 0.100 |
Why?
| | Receptors, Adrenergic, beta | 2 | 2019 | 66 | 0.100 |
Why?
| | Receptors, Muscarinic | 1 | 1993 | 20 | 0.100 |
Why?
| | Arteries | 1 | 2015 | 261 | 0.100 |
Why?
| | Pyramidal Cells | 2 | 2012 | 79 | 0.100 |
Why?
| | Sodium Channel Blockers | 1 | 2012 | 25 | 0.100 |
Why?
| | Subcellular Fractions | 1 | 2012 | 76 | 0.100 |
Why?
| | Tetrodotoxin | 1 | 2012 | 41 | 0.100 |
Why?
| | Gene Expression Regulation | 4 | 2024 | 2621 | 0.100 |
Why?
| | Memory | 2 | 2015 | 266 | 0.090 |
Why?
| | Kainic Acid | 1 | 2012 | 33 | 0.090 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2012 | 106 | 0.090 |
Why?
| | Glucose | 2 | 2021 | 1042 | 0.090 |
Why?
| | Immunoprecipitation | 1 | 2012 | 153 | 0.090 |
Why?
| | GTP-Binding Proteins | 1 | 1993 | 151 | 0.090 |
Why?
| | Vasoconstriction | 1 | 2013 | 216 | 0.090 |
Why?
| | Biophysics | 1 | 2012 | 76 | 0.090 |
Why?
| | Quinoxalines | 1 | 2012 | 67 | 0.090 |
Why?
| | Pyrimidines | 1 | 2016 | 524 | 0.090 |
Why?
| | Cytoskeleton | 2 | 2003 | 193 | 0.090 |
Why?
| | Nociceptors | 1 | 2012 | 41 | 0.090 |
Why?
| | TRPV Cation Channels | 1 | 2012 | 42 | 0.090 |
Why?
| | Ganglia, Spinal | 1 | 2012 | 89 | 0.090 |
Why?
| | Shal Potassium Channels | 1 | 2011 | 5 | 0.090 |
Why?
| | Time Factors | 3 | 2009 | 7032 | 0.080 |
Why?
| | Rats, Wistar | 1 | 2012 | 454 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2015 | 755 | 0.080 |
Why?
| | Indoles | 1 | 2014 | 479 | 0.080 |
Why?
| | Age Factors | 2 | 2009 | 3328 | 0.080 |
Why?
| | Hyperglycemia | 1 | 2013 | 365 | 0.080 |
Why?
| | Calmodulin | 3 | 2012 | 72 | 0.080 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2009 | 10 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2006 | 790 | 0.070 |
Why?
| | Seizures | 1 | 2012 | 454 | 0.070 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1072 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2015 | 420 | 0.070 |
Why?
| | Myocardium | 2 | 2007 | 928 | 0.070 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2009 | 181 | 0.070 |
Why?
| | RNA Interference | 1 | 2009 | 474 | 0.070 |
Why?
| | Sympathetic Fibers, Postganglionic | 1 | 2007 | 4 | 0.070 |
Why?
| | Biotransformation | 1 | 2007 | 62 | 0.060 |
Why?
| | Gene Silencing | 2 | 2020 | 201 | 0.060 |
Why?
| | Nuclear Matrix-Associated Proteins | 1 | 2006 | 7 | 0.060 |
Why?
| | Neurotoxins | 1 | 2006 | 30 | 0.060 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 68 | 0.060 |
Why?
| | Neocortex | 1 | 2006 | 44 | 0.060 |
Why?
| | DNA, Complementary | 2 | 2003 | 277 | 0.060 |
Why?
| | Molecular Sequence Data | 4 | 2014 | 2942 | 0.060 |
Why?
| | Valine | 1 | 2006 | 80 | 0.060 |
Why?
| | Learning | 2 | 2023 | 436 | 0.060 |
Why?
| | Tissue Distribution | 1 | 2006 | 330 | 0.060 |
Why?
| | Mutagenesis | 1 | 2006 | 184 | 0.060 |
Why?
| | Oligopeptides | 1 | 2007 | 266 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2026 | 224 | 0.060 |
Why?
| | Ethanol | 1 | 2009 | 639 | 0.060 |
Why?
| | Neural Inhibition | 2 | 2020 | 176 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 180 | 0.060 |
Why?
| | Drug Interactions | 1 | 2006 | 406 | 0.050 |
Why?
| | Membrane Potentials | 2 | 2012 | 280 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2024 | 2852 | 0.050 |
Why?
| | Cell Polarity | 1 | 2005 | 140 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 894 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2012 | 1736 | 0.050 |
Why?
| | Adenosine Triphosphate | 2 | 2021 | 488 | 0.050 |
Why?
| | rac GTP-Binding Proteins | 1 | 2003 | 34 | 0.050 |
Why?
| | Dogs | 1 | 2005 | 427 | 0.050 |
Why?
| | Insulin Resistance | 1 | 2012 | 1234 | 0.050 |
Why?
| | Water-Electrolyte Balance | 1 | 2003 | 32 | 0.050 |
Why?
| | Cell Adhesion | 1 | 2005 | 456 | 0.050 |
Why?
| | MAP Kinase Kinase Kinases | 1 | 2003 | 71 | 0.050 |
Why?
| | Protein Interaction Mapping | 2 | 2015 | 104 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 132 | 0.050 |
Why?
| | Blotting, Western | 1 | 2006 | 1223 | 0.050 |
Why?
| | Endocannabinoids | 1 | 2024 | 68 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 154 | 0.050 |
Why?
| | Heart | 1 | 2007 | 632 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2003 | 135 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2024 | 211 | 0.050 |
Why?
| | Energy Transfer | 1 | 2002 | 49 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2002 | 70 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 302 | 0.050 |
Why?
| | Protein Subunits | 2 | 2015 | 229 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2010 | 677 | 0.040 |
Why?
| | Plasmids | 1 | 2002 | 371 | 0.040 |
Why?
| | Neurotransmitter Agents | 1 | 2021 | 81 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2021 | 4 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2002 | 404 | 0.040 |
Why?
| | Base Sequence | 2 | 2020 | 2199 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 430 | 0.040 |
Why?
| | Macromolecular Substances | 2 | 2015 | 224 | 0.040 |
Why?
| | Behavior, Animal | 2 | 2015 | 516 | 0.040 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2021 | 195 | 0.040 |
Why?
| | Central Nervous System | 1 | 2021 | 269 | 0.040 |
Why?
| | Bacterial Proteins | 1 | 2006 | 944 | 0.040 |
Why?
| | Acetyltransferases | 1 | 2018 | 21 | 0.040 |
Why?
| | Insulin | 3 | 2021 | 2497 | 0.030 |
Why?
| | Drug-Seeking Behavior | 1 | 2017 | 23 | 0.030 |
Why?
| | Dietary Sucrose | 1 | 2017 | 48 | 0.030 |
Why?
| | Receptors, Dopamine D1 | 1 | 2017 | 36 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2017 | 61 | 0.030 |
Why?
| | Self Administration | 1 | 2017 | 125 | 0.030 |
Why?
| | Biological Transport | 1 | 1998 | 412 | 0.030 |
Why?
| | Cryptochromes | 1 | 2017 | 25 | 0.030 |
Why?
| | Protein Aggregates | 1 | 2017 | 83 | 0.030 |
Why?
| | Genetic Vectors | 1 | 2017 | 342 | 0.030 |
Why?
| | Peptides | 2 | 2013 | 976 | 0.030 |
Why?
| | Arabidopsis Proteins | 1 | 2017 | 72 | 0.030 |
Why?
| | Phenylephrine | 1 | 2015 | 75 | 0.030 |
Why?
| | Cocaine | 1 | 2017 | 171 | 0.030 |
Why?
| | Glutathione Transferase | 1 | 2015 | 99 | 0.030 |
Why?
| | Chlorobenzenes | 1 | 2014 | 20 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1114 | 0.030 |
Why?
| | Phosphoserine | 1 | 2014 | 31 | 0.030 |
Why?
| | Toxins, Biological | 1 | 2013 | 12 | 0.030 |
Why?
| | Maze Learning | 1 | 2014 | 104 | 0.030 |
Why?
| | Adenylate Cyclase Toxin | 1 | 1993 | 6 | 0.020 |
Why?
| | Carbachol | 1 | 1993 | 16 | 0.020 |
Why?
| | Virulence Factors, Bordetella | 1 | 1993 | 15 | 0.020 |
Why?
| | Pertussis Toxin | 1 | 1993 | 23 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2013 | 309 | 0.020 |
Why?
| | Cholera Toxin | 1 | 1993 | 30 | 0.020 |
Why?
| | Fluorometry | 1 | 2012 | 18 | 0.020 |
Why?
| | Ligands | 1 | 2015 | 670 | 0.020 |
Why?
| | CHO Cells | 1 | 1993 | 166 | 0.020 |
Why?
| | Barium | 1 | 2012 | 26 | 0.020 |
Why?
| | Receptors, Cell Surface | 1 | 2015 | 379 | 0.020 |
Why?
| | Cricetinae | 1 | 1993 | 300 | 0.020 |
Why?
| | Second Messenger Systems | 1 | 2012 | 34 | 0.020 |
Why?
| | Insulinoma | 1 | 2012 | 27 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 637 | 0.020 |
Why?
| | Calcium Channels, N-Type | 1 | 2012 | 12 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2012 | 193 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2012 | 120 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2015 | 464 | 0.020 |
Why?
| | Metabolome | 1 | 2015 | 374 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 524 | 0.020 |
Why?
| | Animals, Genetically Modified | 1 | 2012 | 246 | 0.020 |
Why?
| | Dietary Fats | 1 | 2013 | 304 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2015 | 740 | 0.020 |
Why?
| | PDZ Domains | 1 | 2011 | 11 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2012 | 151 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1272 | 0.020 |
Why?
| | Hyperalgesia | 1 | 2012 | 130 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2014 | 566 | 0.020 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 19 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 974 | 0.020 |
Why?
| | Benzylamines | 1 | 2010 | 44 | 0.020 |
Why?
| | Protein Kinases | 1 | 2012 | 310 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 488 | 0.020 |
Why?
| | PC12 Cells | 1 | 2010 | 40 | 0.020 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 21 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1505 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1877 | 0.020 |
Why?
| | Metabolomics | 1 | 2015 | 715 | 0.020 |
Why?
| | Conditioning, Classical | 1 | 2010 | 105 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2009 | 383 | 0.020 |
Why?
| | Leucine Zippers | 1 | 2007 | 16 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2012 | 749 | 0.020 |
Why?
| | Caveolin 3 | 1 | 2007 | 3 | 0.020 |
Why?
| | Discs Large Homolog 1 Protein | 1 | 2007 | 4 | 0.020 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2007 | 22 | 0.020 |
Why?
| | Membrane Microdomains | 1 | 2007 | 34 | 0.020 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2007 | 34 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 2007 | 53 | 0.020 |
Why?
| | Nuclear Envelope | 1 | 2007 | 44 | 0.020 |
Why?
| | Neuromuscular Junction | 1 | 2007 | 65 | 0.020 |
Why?
| | Epistasis, Genetic | 1 | 2006 | 67 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2007 | 249 | 0.020 |
Why?
| | Islets of Langerhans | 1 | 2012 | 825 | 0.010 |
Why?
| | Sulfonamides | 1 | 2010 | 582 | 0.010 |
Why?
| | Extracellular Space | 1 | 2006 | 129 | 0.010 |
Why?
| | Cell Count | 1 | 2006 | 323 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2056 | 0.010 |
Why?
| | Aging | 1 | 2015 | 1946 | 0.010 |
Why?
| | Hypertension | 1 | 2013 | 1260 | 0.010 |
Why?
| | Cell Division | 1 | 2006 | 806 | 0.010 |
Why?
| | Serotonin | 1 | 2006 | 290 | 0.010 |
Why?
| | MAP Kinase Kinase Kinase 3 | 1 | 2003 | 4 | 0.010 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2003 | 6 | 0.010 |
Why?
| | Sorbitol | 1 | 2003 | 13 | 0.010 |
Why?
| | Cell Surface Extensions | 1 | 2003 | 14 | 0.010 |
Why?
| | Pancreatic Neoplasms | 1 | 2012 | 924 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2003 | 34 | 0.010 |
Why?
| | Liver | 1 | 2012 | 1864 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2010 | 963 | 0.010 |
Why?
| | Actin Cytoskeleton | 1 | 2003 | 103 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 273 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2012 | 1787 | 0.010 |
Why?
| | Inflammation | 1 | 2012 | 2881 | 0.010 |
Why?
| | Protein Precursors | 1 | 2000 | 134 | 0.010 |
Why?
| | Glucagon | 1 | 2000 | 111 | 0.010 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2000 | 138 | 0.010 |
Why?
| | Apoptosis | 1 | 2006 | 2519 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1996 | 382 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 1996 | 537 | 0.010 |
Why?
|
|
Dell'Acqua's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|